2.

European Parliament decision of 24 April 2007 on closing the accounts of the European Medicines Agency for the financial year 2005 (C6-0394/2006 — 2006/2161(DEC))

The European Parliament,

- having regard to the final annual accounts of the European Medicines Agency for the financial year 2005 [1],

- having regard to the Court of Auditors' report on the final annual accounts of the European Medicines Agency for the financial year 2005, together with the Agency's replies [2],

- having regard to the Council's recommendation of 27 February 2007 (5711/2007 — C6-0080/2007),

- having regard to the EC Treaty, and in particular Article 276 thereof,

- having regard to Council Regulation (EC, Euratom) No 1605/2002 of 25 June 2002 on the Financial Regulation applicable to the general budget of the European Communities [3], and in particular Article 185 thereof,

- having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency [4], and in particular Article 68 thereof,

- having regard to Commission Regulation (EC, Euratom) No 2343/2002 of 19 November 2002 on the framework Financial Regulation for the bodies referred to in Article 185 of Council Regulation (EC, Euratom) No 1605/2002 [5], and in particular Article 94 thereof,

- having regard to Rule 71 of and Annex V to its Rules of Procedure,

- having regard to the Report of the Committee on Budgetary Control and the opinion of the Committee on the Environment, Public Health and Food Safety (A6-0099/2007),

1. Notes that the final annual accounts of the European Medicines Agency for the financial years 2004 and 2005 are as follows:

Source: The Agency's data — This table summarises the data provided by the Agency in its annual accounts.

(in 1000 EUR) |

Revenue and expenditure account for the financial years 2004 and 2005 |

| 2005 | 2004 |

Revenue

Fees relating to marketing authorisations | 72613 | 68412 |

Commission subsidy including contributions received from the EE | 22847 | 20529 |

Community subsidy for orphan medicines | 6110 | 4026 |

Contributions for Community programmes | 0 | 0 |

Administrative revenue | 3423 | 1973 |

Sundry revenue | 1643 | 1473 |

Total revenue (a) | 106636 | 96413 |

Expenditure

Staff expenditure | 40057 | 34333 |

Administrative expenditure | 17022 | 11224 |

Operating expenditure | 41999 | 38573 |

Depreciation | 5333 | 3650 |

Other expenses | 104 | 280 |

Total expenditure (b) | 104515 | 88060 |

Operating result (c = a-b) | 2121 | 8353 |

Financial result (e) | 2257 | 1160 |

Economic outturn (f = c+e) | 4378 | 9513 |

2. Approves closing the accounts of the European Medicines Agency for the financial year 2005;

3. Instructs its President to forward this decision to the executive director of the European Medicines Agency, the Council, the Commission and the Court of Auditors, and to arrange for its publication in the Official Journal of the European Union (L series).

[1] OJ C 266, 31.10.2006, p. 4.

[2] OJ C 312, 19.12.2006, p. 12.

[3] OJ L 248, 16.9.2002, p. 1. Regulation as amended by Regulation (EC, Euratom) No 1995/2006 (OJ L 390, 30.12.2006, p. 1).

[4] OJ L 136, 30.4.2004, p. 1. Regulation as amended by Regulation (EC) No 1901/2006 (OJ L 378, 27.12.2006, p. 1).

[5] OJ L 357, 31.12.2002, p. 72.

--------------------------------------------------